• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌伴腹膜转移行肉眼下肿瘤完全切除的临床影响。

Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.

机构信息

Second Department of Surgery, Wakayama Medical University, School of Medicine, Wakayama, Japan.

出版信息

Surgery. 2012 Feb;151(2):238-44. doi: 10.1016/j.surg.2010.10.018. Epub 2010 Dec 22.

DOI:10.1016/j.surg.2010.10.018
PMID:21176934
Abstract

BACKGROUND

So far, few reports have focused on the clinicopathological features and patterns of recurrence after a complete resection of peritoneal carcinomatosis (PC) of colorectal origin. The purpose of the present study was to show the clinicopathological features of a macroscopically complete resected tumor and the pattern of recurrence after the curative resection of colorectal PC.

METHODS

In 153 patients with colorectal PC, 31 patients who underwent a complete resection of a synchronous primary lesion of a colorectal PC between 1998 and 2007 were assessed retrospectively.

RESULTS

Clinicopathological differences were observed in the tumor location, presence of extraperitoneal metastases, extent of PC, and presence of lymph node metastases between a macroscopically complete resection and noncomplete resection patients (P = .045, P < .0001, P < .001, and P = .039, respectively). Tumor recurrence after the complete resection of colorectal PC was observed in 24 patients (77.4%). The 5-year survival rate after complete resection was 36.0%. The survival rate in the macroscopically complete resection group was higher than in the incomplete resection group (P < .001). The 5-year intra- and extraperitoneal recurrence survival rates were 63.9% and 33.8%, respectively. No significant clinicopathological factors affected intraperitoneal recurrence-free survival. Conversely, a univariate analysis using the log-rank test revealed that extended PC and presence of lymph node metastases were poor factors affecting extraperitoneal recurrence (P = .009 and P = .023, respectively). Eleven of 31 patients survived for 5 years after resection. Two of the 4 patients with liver metastases had received a hepatectomy.

CONCLUSION

Although the 5-year survival rate after a macroscopically complete resection for colorectal PC approached 36.0%, 77.4% of patients developed intra- and extraperitoneal recurrence. Extended PC and presence of lymph node metastases were poor factors affecting extraperitoneal recurrence.

摘要

背景

目前,鲜有研究报道完整切除结直肠来源腹膜转移瘤(peritoneal carcinomatosis,PC)后的临床病理特征和复发模式。本研究旨在展示结直肠 PC 根治性切除术后大体完全切除肿瘤的临床病理特征和复发模式。

方法

回顾性分析 1998 年至 2007 年间行结直肠 PC 同步原发灶完全切除术的 31 例患者。

结果

在宏观完全切除和非完全切除患者中,肿瘤位置、有无腹膜外转移、PC 程度和有无淋巴结转移存在差异(P =.045,P <.0001,P <.001,P =.039)。24 例患者(77.4%)在结直肠 PC 完全切除术后出现肿瘤复发。完全切除后的 5 年生存率为 36.0%。宏观完全切除组的生存率高于非完全切除组(P <.001)。5 年内腹膜内和腹膜外复发的生存率分别为 63.9%和 33.8%。无明显临床病理因素影响腹膜内无复发生存率。相反,单因素分析显示,广泛的 PC 和淋巴结转移是影响腹膜外复发的不良因素(P =.009 和 P =.023)。31 例患者中有 11 例在切除后存活 5 年。4 例肝转移患者中有 2 例接受了肝切除术。

结论

虽然结直肠 PC 宏观完全切除术后 5 年生存率接近 36.0%,但 77.4%的患者发生腹膜内和腹膜外复发。广泛的 PC 和淋巴结转移是影响腹膜外复发的不良因素。

相似文献

1
Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.结直肠癌伴腹膜转移行肉眼下肿瘤完全切除的临床影响。
Surgery. 2012 Feb;151(2):238-44. doi: 10.1016/j.surg.2010.10.018. Epub 2010 Dec 22.
2
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.意外腹膜癌病是否仍然是结直肠肝转移切除的禁忌症?术中发现结直肠肝转移合并腹膜种植时的联合切除术。
Eur J Surg Oncol. 2013 Sep;39(9):981-7. doi: 10.1016/j.ejso.2013.06.009. Epub 2013 Jul 8.
3
Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.同期合并肝外疾病的转移性结直肠癌患者的肝切除术:单中心127例患者的治疗结果
Ann Surg Oncol. 2009 Aug;16(8):2138-46. doi: 10.1245/s10434-009-0521-6. Epub 2009 Jun 3.
4
Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.结直肠癌腹膜转移癌患者行完全细胞减灭术及围手术期腹腔内化疗后复发疾病的失败分析
Ann Surg Oncol. 2007 Aug;14(8):2281-8. doi: 10.1245/s10434-007-9410-z. Epub 2007 May 15.
5
Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritoneal carcinomatosis.淋巴结比率与结直肠癌腹膜转移患者的生存率相关。
Am Surg. 2011 May;77(5):602-7.
6
Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.高分化消化内分泌癌所致腹膜癌病的外科治疗
Surgery. 2005 Apr;137(4):411-6. doi: 10.1016/j.surg.2004.11.007.
7
Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.结直肠癌合并腹膜转移患者的手术治疗结果。
Br J Surg. 2011 Dec;98(12):1785-91. doi: 10.1002/bjs.7653. Epub 2011 Aug 26.
8
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.结直肠癌肝转移的肝脏手术:10年随访结果。长期生存者、晚期复发及并发症的预后作用。
Ann Surg Oncol. 2008 Sep;15(9):2458-64. doi: 10.1245/s10434-008-9935-9. Epub 2008 May 8.
9
Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.影响结直肠癌根治性切除术后发生肺转移患者肿瘤学结局的因素。
Dis Colon Rectum. 2012 Apr;55(4):459-64. doi: 10.1097/DCR.0b013e318246b08d.
10
Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.结直肠癌肝转移和肺转移的手术切除
J Am Coll Surg. 2006 Mar;202(3):468-75. doi: 10.1016/j.jamcollsurg.2005.11.008. Epub 2006 Jan 18.

引用本文的文献

1
Controversies around the treatment of peritoneal metastases of colorectal cancer.结直肠癌腹膜转移治疗的争议
World J Gastrointest Oncol. 2025 Jan 15;17(1):100199. doi: 10.4251/wjgo.v17.i1.100199.
2
Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.转移性结直肠癌腹膜转移:当前的治疗选择。
Curr Treat Options Oncol. 2018 Sep 1;19(10):49. doi: 10.1007/s11864-018-0563-8.
3
Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer.结直肠癌腹膜转移的细胞减灭术加腹腔热灌注化疗
Indian J Surg Oncol. 2016 Jun;7(2):177-87. doi: 10.1007/s13193-016-0499-z. Epub 2016 Feb 4.
4
Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases.结直肠腹膜转移瘤行不完全手术细胞减灭术联合腹腔内化疗后的结局
World J Gastrointest Oncol. 2015 Dec 15;7(12):445-54. doi: 10.4251/wjgo.v7.i12.445.
5
Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.结直肠或阑尾肿瘤所致腹膜表面恶性肿瘤患者的细胞减灭术及腹腔内热灌注化疗应用指南。
Curr Oncol. 2015 Apr;22(2):e100-12. doi: 10.3747/co.22.2058.
6
Clinical outcome of up-front surgery in patients with asymptomatic, incurable synchronous peritoneal carcinomatosis.有症状不可治愈的同时性腹膜癌病患者行初始手术的临床结果。
Surg Today. 2013 Sep;43(9):984-9. doi: 10.1007/s00595-012-0348-9. Epub 2012 Oct 1.